Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions. Our primary focus is on developing novel drugs which we hope will help treat patients with certain blood cancers or solid tumors.
Karyopharm Therapeutics
Unlock to Claim this listing
Add / Modify Company
Click to rate this company
[Total: 0 Average: 0]
Click here to sign in to vote
4.04
Overall Excellence Rating
Industry
Pharmaceuticals & BiotechnologyCategory
Pharmaceutical ManufacturingESG/Ethical Impact
We are highly committed to policies and practices focused on ESG matters, positively impacting our communities and maintaining and cultivating good corporate governance. By focusing on such policies and practices, we believe we can affect a meaningful and positive change in our communities and maintain our open, collaborative corporate culture. Our Board of Directors oversees our corporate responsibility efforts, primarily through its Nominating, Corporate Governance & Compliance Committee. With their support, we plan to continue to advance our efforts related to corporate responsibility and sustainability initiatives.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received
2023
Revenues
146033000
Website Traffic
Employee Rating
3.9
Customer Rating
Company Size
100-1000
ESG Risk Rating
3
We’re Happy to Help.
Do you have questions about your ranking, our projects, or why you’re not on the list?